These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7599355)

  • 1. Heparin, a possible therapy for diabetic complications: the effect on mesangial and myomedial cells in vivo and in vitro, especially in relation to extracellular matrix.
    Yokoyama H; Myrup B; Oturai P; Deckert T
    J Diabetes Complications; 1995; 9(2):97-103. PubMed ID: 7599355
    [No Abstract]   [Full Text] [Related]  

  • 2. Opioids enhance mesangial cell proliferation and matrix synthesis.
    Singhal PC; Mattana J
    Exp Nephrol; 1994; 2(2):138. PubMed ID: 8082014
    [No Abstract]   [Full Text] [Related]  

  • 3. Diabetes mellitus increases endothelin-1 gene transcription in rat kidney.
    Hargrove GM; Dufresne J; Whiteside C; Muruve DA; Wong NC
    Kidney Int; 2000 Oct; 58(4):1534-45. PubMed ID: 11012888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular matrix contraction by cultured mesangial cells: modulation by transforming growth factor-beta and matrix components.
    Kitamura M; Maruyama N; Mitarai T; Nagasawa R; Yoshida H; Sakai O
    Exp Mol Pathol; 1992 Apr; 56(2):132-43. PubMed ID: 1587339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The glomerular mesangium: a new perspective on its structure and function].
    Rodríguez JH; Méndez Sánchez A; Blanco Rodríguez A; Moyano Navarro T; Gómez-Villamandos JC
    Arch Esp Urol; 1995 Apr; 48(3):229-33. PubMed ID: 7755428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesangial cell dysfunction.
    Kikkawa R; Haneda M; Koya D; Shigeta Y
    J Diabet Complications; 1991; 5(2-3):58-9. PubMed ID: 1770053
    [No Abstract]   [Full Text] [Related]  

  • 7. Heparin increases hillock formation in mesangial cell cultures.
    Ayo SH; Kreisberg JI
    J Am Soc Nephrol; 1991 Dec; 2(6):1153-7. PubMed ID: 1777596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesangial matrix modulation and glomerulosclerosis.
    Fogo AB
    Exp Nephrol; 1999; 7(2):147-59. PubMed ID: 10213868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix accumulation in mesangial cells exposed to cyclosporine A requires a permissive genetic background.
    Fornoni A; Lenz O; Tack I; Potier M; Elliot SJ; Striker LJ; Striker GE
    Transplantation; 2000 Aug; 70(4):587-93. PubMed ID: 10972214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mesangium: interactions between mesangial cells and extracellular matrix].
    Ivić M; Bogićević M; Stefanović V
    Srp Arh Celok Lek; 1994; 122(3-4):96-8. PubMed ID: 17972820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of heparin on mesangial cell growth and gene expression of matrix proteins.
    Wang ZQ; Liang KH; Pahl MV; Vaziri ND
    Nephrol Dial Transplant; 1998 Dec; 13(12):3052-7. PubMed ID: 9870465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin selectively inhibits synthesis of tissue type plasminogen activator and matrix deposition of plasminogen activator inhibitor 1 by human mesangial cells.
    Hagège J; Delarue F; Peraldi MN; Sraer JD; Rondeau E
    Lab Invest; 1994 Dec; 71(6):828-37. PubMed ID: 7807964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High glucose causes an increase in extracellular matrix proteins in cultured mesangial cells.
    Ayo SH; Radnik RA; Garoni JA; Glass WF; Kreisberg JI
    Am J Pathol; 1990 Jun; 136(6):1339-48. PubMed ID: 2356864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin decreases mesangial matrix accumulation after selective antibody-induced mesangial cell injury.
    Tang WW; Wilson CB
    J Am Soc Nephrol; 1992 Oct; 3(4):921-9. PubMed ID: 1450368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infusion of platelet-derived growth factor or basic fibroblast growth factor induces selective glomerular mesangial cell proliferation and matrix accumulation in rats.
    Floege J; Eng E; Young BA; Alpers CE; Barrett TB; Bowen-Pope DF; Johnson RJ
    J Clin Invest; 1993 Dec; 92(6):2952-62. PubMed ID: 7902849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of lipoprotein (a) on mesangial cell biology.
    Greiber S; Wanner C
    Contrib Nephrol; 1997; 120():146-52. PubMed ID: 9257057
    [No Abstract]   [Full Text] [Related]  

  • 17. Regulation of filtration rate by glomerular mesangial cells in health and diabetic renal disease.
    Stockand JD; Sansom SC
    Am J Kidney Dis; 1997 Jun; 29(6):971-81. PubMed ID: 9186087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elastic fiber proteins in the glomerular mesangium in vivo and in cell culture.
    Sterzel RB; Hartner A; Schlötzer-Schrehardt U; Voit S; Hausknecht B; Doliana R; Colombatti A; Gibson MA; Braghetta P; Bressan GM
    Kidney Int; 2000 Oct; 58(4):1588-602. PubMed ID: 11012893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic nephropathy. Mechanisms of mesangial matrix expansion.
    Abrass CK
    West J Med; 1995 Apr; 162(4):318-21. PubMed ID: 7747496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesangial cell turnover: effect of heparin and peptide growth factors.
    Striker LJ; Peten EP; Elliot SJ; Doi T; Striker GE
    Lab Invest; 1991 Apr; 64(4):446-56. PubMed ID: 2016850
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.